Recruiting at 24 sites No phase Atrial Fibrillation (AF)

Atrial Fibrillation study: Sphere-9 Catheter Ablation

Official title Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

ClinicalTrials.gov ID: NCT07298473

What this study is testing

What it's testing
This study is testing whether a redo ablation using the Sphere‑9 catheter and Affera system can help people with recurrent atrial fibrillation.
Who it's for
You may be able to join if you have symptomatic recurrent paroxysmal or persistent atrial fibrillation after one prior ablation.
What's involved
You will have a redo ablation procedure with the Sphere‑9 catheter and Affera system. After the procedure, you will have follow‑up visits for 12 months to check your heart rhythm.
Time commitment
The study lasts about 12 months after your procedure, with scheduled follow‑up visits during that time.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • A physicians' note indicating at least 1 symptomatic AF, AT, or AFL episode occurring within 12 months prior to the enrollment; and
  • At least 1 electrocardiographically documented episode of AF, AT, or AFL within 12 months prior to enrollment 3.

You likely can't join if

  • 1\. Continuous AF lasting for 12 months or longer 2. LA anteroposterior \>55 mm (by MRI, CT, or TTE), or if LA diameter not available, non-index...
  • 40\. Known drug or alcohol dependency 41. Significant congenital anomaly or medical problem that would, in the opinion of the investigator, preclude...
  • \ Women who are of child-bearing potential must undergo a pregnancy test after consent and prior to the study index redo ablation procedure, as...

The study team makes the final eligibility decision.

Where it is enrolling

  • Birmingham, Alabama, United States
  • Los Angeles, California, United States
  • Naples, Florida, United States
  • Orlando, Florida, United States
  • Atlanta, Georgia, United States
  • Savannah, Georgia, United States
  • Boston, Massachusetts, United States
  • Kansas City, Missouri, United States
  • New Hyde Park, New York, United States
  • New York, New York, United States
  • The Bronx, New York, United States
  • Cleveland, Ohio, United States
  • Columbus, Ohio, United States
  • Philadelphia, Pennsylvania, United States
  • Pittsburgh, Pennsylvania, United States
  • Nashville, Tennessee, United States
  • Dallas, Texas, United States
  • Fort Worth, Texas, United States
  • Falls Church, Virginia, United States
  • Lynchburg, Virginia, United States

+ 4 more site(s).

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Birmingham, Alabama, United States; Los Angeles, California, United States; Naples, Florida, United States; Orlando, Florida, United States; Atlanta, Georgia, United States; Savannah, Georgia, United States and 18 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.